These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32060372)

  • 1. An isothermal shift assay for proteome scale drug-target identification.
    Ball KA; Webb KJ; Coleman SJ; Cozzolino KA; Jacobsen J; Jones KR; Stowell MHB; Old WM
    Commun Biol; 2020 Feb; 3(1):75. PubMed ID: 32060372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermal proteome profiling monitors ligand interactions with cellular membrane proteins.
    Reinhard FB; Eberhard D; Werner T; Franken H; Childs D; Doce C; Savitski MF; Huber W; Bantscheff M; Savitski MM; Drewes G
    Nat Methods; 2015 Dec; 12(12):1129-31. PubMed ID: 26524241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing thermal proteome profiling to identify the molecular targets of anti-leishmanial compounds.
    Corpas-Lopez V; Wyllie S
    STAR Protoc; 2021 Sep; 2(3):100704. PubMed ID: 34467225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracking cancer drugs in living cells by thermal profiling of the proteome.
    Savitski MM; Reinhard FB; Franken H; Werner T; Savitski MF; Eberhard D; Martinez Molina D; Jafari R; Dovega RB; Klaeger S; Kuster B; Nordlund P; Bantscheff M; Drewes G
    Science; 2014 Oct; 346(6205):1255784. PubMed ID: 25278616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precipitate-Supported Thermal Proteome Profiling Coupled with Deep Learning for Comprehensive Screening of Drug Target Proteins.
    Ruan C; Ning W; Liu Z; Zhang X; Fang Z; Li Y; Dang Y; Xue Y; Ye M
    ACS Chem Biol; 2022 Jan; 17(1):252-262. PubMed ID: 34989232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target Engagement of Small Molecules: Thermal Profiling Approaches on Different Levels.
    Reckzeh ES; Brockmeyer A; Metz M; Waldmann H; Janning P
    Methods Mol Biol; 2019; 1888():73-98. PubMed ID: 30519941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated Protein Solubility Shift Assays for Comprehensive Drug Target Identification on a Proteome-Wide Scale.
    Zhang X; Ruan C; Wang Y; Wang K; Liu X; Lyu J; Ye M
    Anal Chem; 2023 Sep; 95(37):13779-13787. PubMed ID: 37676971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic drug target deconvolution by mass spectrometry-based technologies.
    Noberini R; Bonaldi T
    Nat Struct Mol Biol; 2019 Oct; 26(10):854-857. PubMed ID: 31582842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomics of kinase inhibitor targets and mechanisms.
    Daub H
    ACS Chem Biol; 2015 Jan; 10(1):201-12. PubMed ID: 25474541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a σ
    Wilke J; Kawamura T; Xu H; Brause A; Friese A; Metz M; Schepmann D; Wünsch B; Artacho-Cordón A; Nieto FR; Watanabe N; Osada H; Ziegler S; Waldmann H
    Cell Chem Biol; 2021 Jun; 28(6):848-854.e5. PubMed ID: 33567254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Proteomics-Based Drug Mechanism-of-Action Studies Using 16-Plex Isobaric Mass Tags.
    Zinn N; Werner T; Doce C; Mathieson T; Boecker C; Sweetman G; Fufezan C; Bantscheff M
    J Proteome Res; 2021 Mar; 20(3):1792-1801. PubMed ID: 33621079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteome-Wide Deconvolution of Drug Targets and Binding Sites by Lysine Reactivity Profiling.
    Ruan C; Zhou J; Li Z; Li K; Fang Z; Zhang X; Ye M
    Anal Chem; 2022 Feb; 94(7):3352-3359. PubMed ID: 35147412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical proteomics and its impact on the drug discovery process.
    Miao Q; Zhang CC; Kast J
    Expert Rev Proteomics; 2012 Jun; 9(3):281-91. PubMed ID: 22809207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability-based approaches in chemoproteomics.
    George AL; Dueñas ME; Marín-Rubio JL; Trost M
    Expert Rev Mol Med; 2024 Apr; 26():e6. PubMed ID: 38604802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical proteomics: terra incognita for novel drug target profiling.
    Huang F; Zhang B; Zhou S; Zhao X; Bian C; Wei Y
    Chin J Cancer; 2012 Nov; 31(11):507-18. PubMed ID: 22640626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target deconvolution from phenotype-based drug discovery by using chemical proteomics approaches.
    Kubota K; Funabashi M; Ogura Y
    Biochim Biophys Acta Proteins Proteom; 2019 Jan; 1867(1):22-27. PubMed ID: 30392561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying drug targets in tissues and whole blood with thermal-shift profiling.
    Perrin J; Werner T; Kurzawa N; Rutkowska A; Childs DD; Kalxdorf M; Poeckel D; Stonehouse E; Strohmer K; Heller B; Thomson DW; Krause J; Becher I; Eberl HC; Vappiani J; Sevin DC; Rau CE; Franken H; Huber W; Faelth-Savitski M; Savitski MM; Bantscheff M; Bergamini G
    Nat Biotechnol; 2020 Mar; 38(3):303-308. PubMed ID: 31959954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The application of small molecule bioactive probes in the identification of cellular targets].
    Zhang J; Zhou HC
    Yao Xue Xue Bao; 2012 Mar; 47(3):299-306. PubMed ID: 22645752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying small molecule microarrays and resulting affinity probe cocktails for proteome profiling of mammalian cell lysates.
    Shi H; Uttamchandani M; Yao SQ
    Chem Asian J; 2011 Oct; 6(10):2803-15. PubMed ID: 21898842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison of Two Stability Proteomics Methods for Drug Target Identification in OnePot 2D Format.
    Xu Y; West GM; Abdelmessih M; Troutman MD; Everley RA
    ACS Chem Biol; 2021 Aug; 16(8):1445-1455. PubMed ID: 34374519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.